- Home
- WAL vs ARWR Comparison
WAL vs ARWR Comparison
Compare WAL & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WAL | ARWR |
|---|---|---|
| Founded | 1994 | 2003 |
| Country | United States | United States |
| Employees | 3524 | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.6B | 10.2B |
| IPO Year | N/A | 2009 |
Fundamental Metrics
Financial Performance| Metric | WAL | ARWR |
|---|---|---|
| Price | $80.53 | $73.10 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 10 |
| Target Price | ★ $91.69 | $83.40 |
| AVG Volume (30 Days) | 1.0M | ★ 1.5M |
| Earning Date | 04-21-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.11% | N/A |
| EPS Growth | N/A | ★ 99.80 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $16,142,321.00 |
| Revenue This Year | $20.49 | N/A |
| Revenue Next Year | $8.08 | N/A |
| P/E Ratio | $10.88 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $65.82 | $14.30 |
| 52 Week High | $97.23 | $82.26 |
Technical Indicators
Market Signals| Indicator | WAL | ARWR |
|---|---|---|
| Relative Strength Index (RSI) | 54.64 | 46.21 |
| Support Level | $74.06 | $70.49 |
| Resistance Level | $81.21 | $77.39 |
| Average True Range (ATR) | 2.00 | 3.63 |
| MACD | 0.20 | -0.89 |
| Stochastic Oscillator | 85.48 | 26.81 |
Price Performance
Historical ComparisonAbout WAL Western Alliance Bancorporation (DE)
Western Alliance Bancorp provides a full spectrum of customized loan, deposit, and treasury management capabilities, including funds transfer and other digital payment offerings. The company's reportable segments are Commercial segment includes provides commercial banking and treasury management products and services to small and middle-market businesses, specialized banking services to sophisticated commercial institutions and investors within niche industries, as well as financial services to the real estate industry. Consumer Related segment offers both commercial banking services to enterprises in consumer-related sectors and consumer banking services, such as residential mortgage banking and Corporate & Other.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is a commercial-stage pharmaceutical company. It is focused on the development of medicines for diseases associated with genetic abnormalities or protein overproduction. The company develops potential RNAi therapies designed to inhibit the expression of genes known to trigger diseases. Its portfolio includes potential drugs targeting Cardiometabolic, Neuromuscular, Pulmonary, Liver, and other diseases. The company also develops RNAi products and clinical candidates designed to target different cell types within the body.